Explore

Rapid Read Rapid Read
Moderna Advances mRNA Vaccine for Ebola with Phase I Trial Launch

Moderna Advances mRNA Vaccine for Ebola with Phase I Trial Launch

Moderna has initiated a Phase I clinical trial for its mRNA-1469 vaccine, targeting the Bundibugyo strain of the Ebola virus. This development follows authorization from Health Canada, marking a significant step in combating the ongoing Ebola outbreak in the Democratic Republic of the Congo. The trial is part of a collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI), which has committed up to $50 million to support the vaccine's development. The Bundibugyo strain has been responsible for over 3,000 confirmed cases and more than 1,400 deaths. Moderna's CEO, Stéphane Bancel, emphasized the importance of this milestone, noting the lack of an approved vaccine for this strain. The collaboration aims to rapidly advance to larger Phase II and III trials if initial results are promising.
Rapid Read Rapid Read
Moderna Initiates Phase 1 Clinical Trial for Ebola Vaccine Targeting DRC Strain

Moderna Initiates Phase 1 Clinical Trial for Ebola Vaccine Targeting DRC Strain

Moderna has commenced a Phase 1 clinical trial for an Ebola vaccine targeting the Bundibugyo strain, currently affecting the Democratic Republic of the Congo (DRC). The trial, conducted in Canada, will assess the vaccine's safety and tolerability using Moderna's mRNA platform, previously utilized for COVID-19 vaccines. The trial involves 80 participants and is supported by the Coalition for Epidemic Preparedness Innovations (CEPI), which has committed up to $50 million for preclinical testing and the trial. The vaccine aims to address the ongoing Ebola outbreak in the DRC, which has resulted in over 3,700 cases and 1,600 deaths.
Rapid Read Rapid Read
Health Canada Approves Moderna's mRNA Vaccine Trial Amid Congo Ebola Outbreak

Health Canada Approves Moderna's mRNA Vaccine Trial Amid Congo Ebola Outbreak

Health Canada has authorized Moderna to conduct a Phase 1 clinical trial for a vaccine targeting the Bundibugyo strain of the Ebola virus, which is currently causing a significant outbreak in the Democratic Republic of the Congo. This outbreak has resulted in over 3,800 confirmed cases and more than 1,700 deaths. The trial will take place at three sites in Canada and will involve approximately 80 participants. The vaccine uses mRNA technology, similar to that used in COVID-19 vaccines. This development comes as the outbreak continues to spread across multiple provinces in Congo, with health officials struggling to contain it due to violence and mistrust in affected areas.
Rapid Read Rapid Read
Health Canada Authorizes Clinical Trial for Ebola Vaccine by Moderna

Health Canada Authorizes Clinical Trial for Ebola Vaccine by Moderna

Health Canada has approved a Phase I clinical trial for Moderna's mRNA vaccine targeting the Bundibugyo strain of Ebola. This strain is responsible for a significant outbreak in the Democratic Republic of the Congo. The trial will assess the vaccine's safety, dosage, and side effects in healthy participants. Canada is the second country to authorize such a trial, following the U.K. The trial is part of a broader effort to develop a vaccine for this strain, which currently has no approved treatment.
Rapid Read Rapid Read
Health Canada Approves Clinical Trial for Moderna's mRNA Ebola Vaccine Amidst Outbreak

Health Canada Approves Clinical Trial for Moderna's mRNA Ebola Vaccine Amidst Outbreak

Health Canada has authorized Moderna to conduct a Phase I clinical trial for an mRNA vaccine targeting the Bundibugyo strain of the Ebola virus, which is currently causing a significant outbreak in the Democratic Republic of the Congo. This approval makes Canada the second country, after the U.K., to authorize such a trial. The trial will assess the immune response of participants to the vaccine, which does not involve injecting the virus itself. This development is part of a broader effort to address the lack of licensed vaccines for this particular strain of Ebola.
Rapid Read Rapid Read
Ebola Outbreak in Democratic Republic of the Congo Outpaces Response Efforts

Ebola Outbreak in Democratic Republic of the Congo Outpaces Response Efforts

The Democratic Republic of the Congo is experiencing the fastest-growing Ebola outbreak in history, with over 1,700 deaths recorded in just 14 weeks. Despite the rapid rollout of trials for new and experimental vaccines and treatments, the outbreak continues to outpace response efforts. The outbreak is concentrated in eastern Congo, a region plagued by decades of violence, which has hindered access to communities and disrupted the movement of personnel and supplies. The World Health Organization (WHO) has been able to start trials more quickly compared to previous outbreaks, but the Bundibugyo ebolavirus, a rare strain causing the current outbreak, has no existing vaccines or treatments. Efforts are underway to test experimental treatments and vaccines, including a phase 1 clinical trial by Moderna in Canada.
Rapid Read Rapid Read
Moderna Begins Ebola Vaccine Trial as FDA Decision on Flu Shot Looms

Moderna Begins Ebola Vaccine Trial as FDA Decision on Flu Shot Looms

Moderna has initiated a Phase 1 clinical trial for its experimental Ebola vaccine targeting the Bundibugyo strain. The trial, conducted in Canada, will assess the vaccine's safety and immune response in 80 adults. This development comes as the U.S. FDA is set to decide on Moderna's seasonal influenza vaccine for adults aged 50 and older. The Ebola vaccine trial is supported by the Coalition for Epidemic Preparedness Innovations, which has committed up to $50 million for early development.
Rapid Read Rapid Read
WHO Accelerates Trials Amidst Deadly Ebola Outbreak in DR Congo

WHO Accelerates Trials Amidst Deadly Ebola Outbreak in DR Congo

The Democratic Republic of the Congo is experiencing a severe Ebola outbreak, with over 1,700 deaths reported. The World Health Organization (WHO) is accelerating trials for experimental treatments, preventive medicines, and vaccines. The outbreak is concentrated in the Ituri province, which accounts for nearly 90% of cases. The response has been hampered by delays in contact tracing, violence, and mistrust of health authorities. The outbreak is the second-largest on record and is spreading rapidly, with more than 100 healthcare workers infected. The WHO is working to address these challenges and is monitoring over 17,000 potential contacts.
Rapid Read Rapid Read
DR Congo's Ebola Outbreak Becomes Second-Deadliest in History

DR Congo's Ebola Outbreak Becomes Second-Deadliest in History

The Ebola outbreak in the Democratic Republic of the Congo has become the second-deadliest in history, with 3,695 cases and 1,623 deaths reported. The outbreak, caused by the Bundibugyo strain, is intensifying, with increasing transmission rates and a high case fatality ratio. The World Health Organization (WHO) reports that Ituri province is the most affected, accounting for the majority of cases and deaths. The outbreak is impacting maternal mortality rates, as women avoid medical centers due to fear of contracting Ebola. The WHO emphasizes the need for a substantial scaling up of response activities to control the outbreak.
Reuters Reuters
Why Congo's Ebola outbreak is spreading faster than previous epidemics

Why Congo's Ebola outbreak is spreading faster than previous epidemics

By Clement Bonnerot and Jessica Donati DAKAR, Aug 5 (Reuters) - The Ebola epidemic in Democratic Republic of Congo is on track to surpass 4,000 cases this week and has been described as the fastest spreading on record since it was officially declared in May.  
Reuters Reuters
Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna begins first human trial of Bundibugyo Ebola vaccine

Aug 4 (Reuters) - Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus, a strain of Ebola that has killed more than 1,650 people so far and currently has no approved vaccine.  
AP News AP News
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges

Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges

Ebola has killed over 1,700 people in eastern Congo, marking the fastest-growing outbreak of the disease